Purchase Order 80NSSC21P2233
Award Date 7/29/21
Potential Completion Date 8/31/22
Potential Value $181K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the purchase of reagents by the National Aeronautics and Space Administration (NASA) Shared Services Center. The contract was awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The firm fixed-price purchase order has a potential value of $142,504.77 and was awarded on June 28, 2019, with a completion date of February 19, 2021. No set-aside designation was used. Illumina has previously been awarded prime federal...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $241,495.60 firm fixed price delivery order is for the provision of various Illumina reagent supplies, with no set-aside designation. Illumina has previously received prime contracts and subcontracts from HHS, the Centers for Disease Control and Prevention,...
- This is a firm fixed-price delivery order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $872,996.22 award is for the provision of Illumina reagent kits to support genomic analysis and sequencing work. This order falls under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy's Bureau of Medicine and...
- This is a firm fixed price purchase order awarded by the National Aeronautics and Space Administration (NASA) Shared Services Center to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $233,302.47 award is for reagents to support the NASA GeneLab project, which requires various reagents compatible with Illumina sequencing platforms like the NovaSeq 6000 and iSeq 100 for generating sequencing libraries, clusters, and data from biological samples...
- This federal contract award to Illumina, Inc. is for the provision of laboratory supplies in the form of sequencing reagent kits. The $139,612.03 fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging, and does not utilize any set-aside provisions. Illumina, a manufacturer of genomic sequencing instruments and consumables, has been awarded numerous past federal contracts to supply its proprietary...
- The U.S. Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order worth $206,046.90 to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The award is for the provision of "REAGENT (CHEMISTRY) KITS" and does not include any set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the NIH, CDC, USDA, and VA to provide a range of genomic sequencing technologies...
- This federal contract award was issued by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, to Illumina, Inc. The $163,848 firm fixed price delivery order is for the provision of Illumina's sequencing systems, reagents, and maintenance services to support genomic sequencing and analysis. Illumina has previously received prime contracts and subcontracts from various federal agencies, including the CDC, USDA, and VA, to provide a range of Illumina's...
- This is a $248,752.36 firm fixed price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the provision of reagent kits to support the agency's chemistry research and analysis. Illumina has a history of providing sequencing systems, consumables, and support services to various federal agencies including the NIH, CDC, USDA, and...
- This is a $116,924.36 firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The order is for the provision of biological kits and reagents, with no set-aside designation. Through past prime federal contract awards, Illumina has supplied a range of sequencing systems, consumables, and services to support genomic...
- This firm fixed-price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $136,783.84 contract is for the provision of Illumina reagent kits to support genomic sequencing and analysis for research and diagnostic purposes. The award has a completion date of August 2, 2023. Illumina...